Synartro AB
556866-4220ActiveDeveloping sustained local injection treatments for osteoarthritis pain relief.
Clinical Stage Life Science Companysynartro.com
Oversigt
- 1–4
- Medarbejdere
- ≤1t SEK
- Omsætning
- 2011
- Grundlagt
Nøglebeslutningstagere
Magnus Hurst
CFO & acting CEO
@synartro.com+46760XXXXXX
Antonio Bermejo Gómez
Chief Development Officer
@synartro.com+46760XXXXXX
Mats Persson
Board Member
@synartro.com
Maria Nyhage
Board Member
@synartro.com
+2 flere kontakter i Funnelfeedr
Beskrivelse
Synartro AB is a clinical stage Swedish life science company focused on developing novel local injection treatments for osteoarthritis (OA). Their core innovation lies in a patented technology that chemically binds existing, proven drugs to a base compound. This process enables sustained drug releas...
REGENARTI AS